SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV
Matthew A. Spinelli, Lillian B. Brown, David V. Glidden, Kyle Hunter, Patrick Martin-Tuite, James Zheng, Curtis Sera, Diane Havlir, Susan P. Buchbinder, Monica Gandhi
Abstract
To assess SARS-CoV-2 outcomes, we matched a municipal COVID-19 registry and clinic rosters from a municipal primary care network containing a large HIV clinic and assessed clinical outcomes by HIV status. The risk of severe COVID-19 was higher among people with HIV (PWH, adjusted relative risk = 1.84, 95% confidence interval = 1.05-3.25), while SARS-CoV-2 incidence was lower despite higher testing rates. SARS-CoV-2 vaccination campaigns should prioritize PWH to prevent severe COVID-19 disease given potentially higher risk.
Topics & Concepts
MedicineConfidence intervalIncidence (geometry)Human immunodeficiency virus (HIV)SidaRelative riskVaccinationPrimary careViral diseaseRisk assessmentDiseaseHealth careEpidemiologyYoung adultImmunopathologyRisk factorPublic healthPediatricsPrimary health careCohort studyFamily medicineCumulative incidenceMEDLINECross-sectional studyEmergency medicineSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies